About Michelle
Michelle began her career in the pharmaceutical industry at Roche, first in the UK before transitioning to California.
Since her time at Roche, Michelle has progressed through various companies and diverse roles encompassing market research, competitive intelligence, and market analytics, advancing to increasingly senior positions.
Her professional journey has included roles at notable organizations such as AstraZeneca, Genentech as well as smaller biotechs Theravance, Emergent, and Vir.
​
Michelle holds a PhD in immunology from the University of Portsmouth, complemented by an MBA from the University of San Francisco.
Experience
Michelle's experience spans many therapeutic areas such as oncology, inflammation, neurology, and infectious diseases. She has worked on a wide range of assets including small molecules, monoclonal antibodies, and vaccines.
​
Throughout her career, Michelle has been involved in projects at every stage of development, from initial research concepts to pre-launch strategies. She has also played a key role in numerous business development assessments, conducting both search and evaluation through detailed due diligence.